insulin lispro protamine + insulin lispro

Insulin lispro protamine + insulin lispro is a premixed insulin analog formulation consisting of a rapid-acting insulin analog (insulin lispro) and an intermediate-acting insulin analog (insulin lispro protamine). This combination is designed to provide both prandial (mealtime) and basal (background) glycemic control in patients with diabetes mellitus. The insulin lispro component acts quickly to manage postprandial glucose spikes, while the protamine-crystallized component provides a prolonged duration of action. This specific product is a biosimilar candidate of Humalog Mix, developed through a collaboration between Tonghua Dongbao Pharmaceutical and Nanjing King-Friend Biochemical Pharmaceutical, intended for global markets including the United States.

Brand names

Gulailin 25Gulailin25Gulailin-25Gulailin 50Gulailin50Gulailin-50

Other names

insulin lispro protamine suspension and insulin lispro injectionbiphasic insulin lispropremixed insulin lispro